Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2021 | Future approaches to treating colorectal cancer

Bruna Pellini • 7 Apr 2021
AACR 2021
Colorectal Cancer Gastrointestinal Cancer

Bruna Pellini, MD, Moffitt Cancer Center, Tampa, FL, shares her thoughts on the future of treatment for patients with colorectal cancer, highlighting the role of precision medicine, the need for novel combinations of chemotherapy and immunotherapy, and the role of molecular profiling incorporating tumor mutational burden and circulating tumor DNA. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

More from Bruna Pellini

3:44
Evaluating the use of ctDNA as a biomarker in lung cancer
Bruna Pellini • 21 Feb 2024
5:12
How can ctDNA assess MRD and profile tumor types in lung cancer?
Bruna Pellini • 21 Feb 2024
1:07
ctDNA MRD detection in patients with NSCLC
Bruna Pellini • 5 Jun 2022
0:56
ctDNA sensitivity in early-stage disease
Bruna Pellini • 5 Jun 2022

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals